Laboratory Response to 2014 Ebola Virus Outbreak in MaliJOURNAL OF INFECTIOUS DISEASESIF4.52016-10-0515OAAI
Stool microbiome reveals diverse bacterial ureases as confounders of oral urea breath testing for Helicobacter pylori and Mycobacterium tuberculosis in Bamako, MaliJOURNAL OF BREATH RESEARCHIF3.42016-08-1711OAAI
Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivoPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12016-02-08323OAAI
Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvirAIDSIF3.12016-01-0123OAAI
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 InfectionANNALS OF INTERNAL MEDICINEIF15.22015-12-1552OAAI
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a studyHEPATOLOGY INTERNATIONALIF6.12015-11-2655OAAI
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver DiseaseCLINICAL INFECTIOUS DISEASESIF7.32015-10-2628OA
Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort studyLANCET INFECTIOUS DISEASESIF312015-09-01125OAAI
Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infectionJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552015-03-24174OAAI
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort studyLANCETIF88.52015-03-01129OAAI
Treatment of Hepatitis C Virus Infection: Is It Time for the Internist to Take the Reins?ANNALS OF INTERNAL MEDICINEIF15.22014-09-1616PREAI
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcomeJOURNAL OF CLINICAL INVESTIGATIONIF13.62014-07-01186OAAI
USE OF SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION FOR TREATMENT OF HCV GENOTYPE-1 IN PATIENTS COINFECTED WITH HIVJOURNAL OF HEPATOLOGYIF332014-04-016PREAI
Comparative Efficacy, Pharmacokinetic, Pharmacodynamic Activity, and Interferon Stimulated Gene Expression of Different Interferon Formulations in HIV/HCV Genotype-1 Infected PatientsJOURNAL OF MEDICAL VIROLOGYIF4.62013-10-264PREAI
HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear FashionJOURNAL OF VIROLOGYIF3.82013-09-15119OAAI
Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics A Randomized Clinical TrialJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552013-08-28254OA
Adjuvant Host-Directed Therapy with Types 3 and 5 but Not Type 4 Phosphodiesterase Inhibitors Shortens the Duration of Tuberculosis TreatmentJOURNAL OF INFECTIOUS DISEASESIF4.52013-05-0245OAAI
High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV干扰素刺激的高基因ISG-15表达影响合并感染HIV和HCV的患者的HCV治疗结果JOURNAL OF MEDICAL VIROLOGYIF4.62013-04-1210PREAI
ALTERED HCV SPECIFIC T CELL IMMUNITY VERY EARLY IN INTERFERON FREE HCV DAA THERAPYJOURNAL OF HEPATOLOGYIF332013-04-0111OAAI